04 February, 2017
While much work remains to find a cure for cancer – the good news is we know that many forms of cancer are preventable. On World Cancer Day, a moment when the global community comes together to reflect on tho...
Published on 04th February
While much work remains to find a cure for cancer – the good news is we know that many forms of cancer are preventable. On World Cancer Day, a moment when the global community comes together to reflect on those lost to cancer, as well as the advances we need to make to find a cure, it’s important to remember that there are actions that governments and individuals can take to prevent cancer. In fact, governments hold many levers that can actually address this leading killer.
…Almost everyone has a friend or loved one who has battled cancer. Every year, cancer claims more than 8 million lives. Unless we act, by 2030 the number of annual cancer deaths could reach 13 million. But we don’t have to accept that, because another future is possible…
Statement from Michael Bloomberg on World Cancer Day
For example, governments – both at the national and municipal levels – can and should take on tobacco. A staggering twenty-two percent of all cancer deaths are tobacco-related. One of the most effective strategies to cut into tobacco use is to raise tobacco taxes, which not only reduces use but also increases government revenue. When Bloomberg Philanthropies founder Mike Bloomberg served as Mayor of New York City, mortality rates from cancer declined 6.4% compared to 2001.
While we can’t definitively say this was the direct result of one action, we do know that efforts to curb tobacco – like implementing bans on smoking in work places and public spaces, raising the price through increased taxes, and airing hard-hitting media campaigns, had important impact.
Bloomberg Philanthropies has worked with over 59 governments since 2007 and many of them have successfully passed tobacco control laws, including several major Chinese cities, India, and Bangladesh. By using the World Health Organization’s MPOWER package of interventions, we estimate that at least 30 million lives have been saved.
Regular screening for breast and cervical cancer increases the chances of early detection and treatment, so making women’s health affordable and accessible is also essential.
Another step that governments can take to address cancer rates is addressing obesity. Obesity is linked with an increased risk in several cancers, including kidney, pancreatic, and breast cancer. Thus, research shows that roughly one-third of common cancers can be prevented by eating a healthy diet, maintaining a healthy weight, and incorporating physical exercise.
Bloomberg Philanthropies has been spreading evidence-based strategies in high-burden areas, such as raising taxes on sugary beverages, reducing marketing of unhealthy foods to children, and promoting easy-to-understand nutrition labels on packaged foods. But foundations like Bloomberg Philanthropies need government partners who are willing to move these policies forward.
Cancer is just one kind of noncommunicable disease. Shockingly, noncommunicable diseases and injuries account for almost 80% of global deaths but only 2% of foreign aid globally. Governments are paramount to reducing cancer and other noncommunicable diseases because they have the authority to adapt these evidence-based solutions into policies that can reduce risk and they can dedicate resources to research and treatment.
It’s time for governments to prioritize noncommunicable diseases and that’s why on World Cancer Day we’re calling on governments to join Mike Bloomberg, as the World Health Organization’s Global Ambassador for Noncommunicable Diseases, to do more!
This editorial/ Op-Ed was developed by Bloomberg Philanthropies Public Health Program on World Cancer Day 2017.
Last Editorial Review: February 4, 2017
Featured Image: Laser therapy of cancer, conceptual image. 3D illustration. Courtesy: © Fotolia. Used with permission. Image 1.0: World Cancer Day poster with calligraphy/February 4th. Courtesy: © Fotolia. Used with permission.
Copyright © 2017 InPress Media Group. All rights reserved. Republication or redistribution of InPress Media Group content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group. InPress Media Group shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. ADC Review / Journal of Antibody-drug Conjugates is a registered trademarks and trademarks of InPress Media Group around the world.